Tumor ICT, also known as tumor immune checkpoint blockade, becomes a new treatment for cancer since the first antibody targeting CTLA-4 was discovered by Nobel laureate James P. Allison (72, 73). The gene discussed is CTLA4; the disease is neoplasm.